Where are you calling from? <a href=\" http://www.vision-ar.com/mediablog/pay-day-advance-online/#actually \">roy cash</a> Getting a partner for Spedra in Europe will take the heat off Vivus management for a little while as it prepares to fend off pressure from its major shareholder, First Manhattan Co, for control of the firm. The latter has been disparaging about the disappointing launch of the obesity drug Qsymia (phentermine/topiramate) and is looking to get its slate of directors elected to the board at the annual general meeting next week. <a href=\" http://www.pensionfreedom.ie/cash-advance-birmingham#ton \">100 approval pay day loans</a> \"The ISS seal of approval makes the Silver Lake/Michael Delldeal more likely to receive shareholder approval,\" Brian White,analyst at Topeka Capital Markets said, adding that ISS viewsIcahn\'s bid \"as coming with too much uncertainty.\"
# | Item | Wins | Losses | Wins + Losses | Score |
---|---|---|---|---|---|
1 | Where are you calling from? <a href=\" http://www.vision-ar.com/mediablog/pay-day-advance-online/#actually \">roy cash</a> Getting a partner for Spedra in Europe will take the heat off Vivus management for a little while as it prepa | 0 | 0 | 0 | 0 |
2 | First Manhattan Co | 0 | 0 | 0 | 0 |
3 | for control of the firm. The latter has been disparaging about the disappointing launch of the obesity drug Qsymia (phentermine/topiramate) and is looking to get its slate of directors elected to the board at the annual general meeting next week. <a h | 0 | 0 | 0 | 0 |
4 | \" Brian White | 0 | 0 | 0 | 0 |
5 | analyst at Topeka Capital Markets said | 0 | 0 | 0 | 0 |
6 | adding that ISS viewsIcahn\'s bid \"as coming with too much uncertainty.\" | 0 | 0 | 0 | 0 |
Back to the polls!